Table 3.
Key points | |
---|---|
(i) Surgical resection is the only curative treatment for patients with PNETs. | |
(ii) The incidence of PNETs has increased during the last decades. | |
(iii) PNETs are clinically diverse and divided in functioning and nonfunctioning disease. | |
(iv) The ENETS TNM staging system is superior to the UICC/AJCC/WHO 2010 TNM staging system in terms of prognostic stratification for patients with PNETs. | |
(v) There has been a trend towards more aggressive surgery as well as more minimally invasive surgery in patients with PNETs over the last decade. | |
(vi) Lymph node sampling should be performed routinely after curative resection of PNETs, as lymph node ratio is a significant predictor of recurrence. | |
(vii) The five- and 10-year survival rates for all PNETs are about 65% and 45%. | |
(viii) Long-term followup of patients having undergone surgical treatment for nonfunctioning PNETs is essential due to the risk of late recurrence. |